Copper-mediated novel cell death pathway in tumor cells and implications for innovative cancer therapies

Xiaodan Zhang1, Tao Tao2, Yishu Qiu3

  • 1Department of Immunology, School of Medicine, Nantong University, Nantong, China; Computational Systems Biology Lab (CSBL), The Marine Biomedical Research Institute, Guangdong Medical University, Zhanjiang, China.

Insights

Copper death is a novel cell death pathway dependent on intracellular copper levels and mitochondrial respiration. This mechanism offers a promising avenue for targeted cancer therapies by exploiting tumor cell metabolic differences.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Diverse cell death pathways like apoptosis and necrosis are used in cancer therapy.
  • Copper death is a newly identified cell death modality linked to intracellular copper.
  • Tumor cells have unique metabolic profiles and higher copper content than normal cells.

Purpose of the Study:

  • To introduce the proteins and mechanisms of copper death.
  • To review the role of copper death in various tumor types.
  • To provide a reference for developing targeted cancer therapies.

Main Methods:

  • Literature review of existing research on copper death.
  • Analysis of copper metabolism in cancer cells.
  • Examination of copper death's impact on different tumor models.

Main Results:

  • Copper death relies heavily on mitochondrial respiration and the tricarboxylic acid (TCA) cycle.
  • Elevated intracellular copper levels can trigger this cell death pathway.
  • Copper death mechanisms differ significantly from other known cell death types.

Conclusions:

  • Copper death presents a novel therapeutic target for cancer treatment.
  • Understanding copper death pathways can lead to personalized cancer therapies.
  • Further research into copper death proteins and mechanisms is crucial for clinical applications.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
933